Abstract:Objective To observe the clinical effect of plasma infusion in the treatment of delayed encephalopathy after carbon monoxide poisoning (DEACMP). Methods A total of 70 patients with DEACMP admitted to Jining NO.1 People′s Hospital from July 2017 to May 2021 were selected as the research objects, and they were divided into the control group and the experimental group according to random number table method, with 35 cases in each group. The control group was treated with routine medical treatment, while the experimental group received plasma infusion therapy on the basis of the control group. The Montreal cognitive assessment (MoCA) score, clinical effect, daily living ability score were compared between the two groups. Results Before treatment, there were no significant differences in the scores of MoCA and daily living ability between the two groups (P>0.05). After treatment of 14 days, there was no significant difference in MoCA scores between the two groups (P>0.05). After treatment of 14 days, the MoCA scores of the two groups were higher than those before treatment (P<0.05). After treatment of three months, daily living ability score in the experimental group was higher than that in the control group and before treatment, the difference was statistically significant (P<0.05). The treatment total effective rate of in the experimental group was higher than that in the control group, and the difference was statistically significant (P<0.05). Conclusion The combined use of plasma infusion therapy on the basis of routine medical treatment can effectively improve the cognitive function and daily living ability in DEACMP patients.
姬晓昙; 卢启秀; 颜丙旺; 王理祥; 刘厚林. 血浆输注治疗一氧化碳中毒迟发性脑病的临床效果[J]. 中国当代医药, 2022, 29(19): 94-97.
JI Xiaotan; LU Qixiu; YAN Bingwang; WANG Lixiang; LIU Houlin. Clinical effect of plasma infusion in the treatment of delayed encephalopathy after carbon monoxide poisoning. 中国当代医药, 2022, 29(19): 94-97.
Inagaki T,Ishino H,Seno H,et al.A long-term follow-up study of serial magnetic resonance images in patients with delayed encephalopathy after acute carbon monoxide poisoning[J].Psychiatry Clin Neurosci,1997,51(6):421-423.
[2]
Mattiuzzi C,Lippi G.Worldwide epidemiology of carbon monoxide poisoning[J].Hum Exp Toxicol,2020,39(4):387-392.
[3]
Zhang YJ,Yu BX,Wang NN,et al.Acute poisoning in Shenyang,China:a retrospective and descriptive study from 2012 to 2016 [J].BMJ Open,2018,8(8):e021881.
[4]
Wang XH,Li ZY,Berglass J,et al.MRI and clinical manifestations of delayed encephalopathy after carbon monoxide poisoning[J].Pak J Pharm Sci,2016,29(6 Suppl):2317-2320.
Hu HJ,Pan XW,Wan Y,et al.Factors affecting the prognosis of patients with delayed encephalopathy after acute carbon monoxide poisoning[J].Am J Emerg Med,2011,29(3):261-264.
Liu J,Si Z,Liu J,et al.Clinical and imaging prognosis in patients with delayed encephalopathy after acute carbon monoxide poisoning[J].Behav Neurol,2020,2020:1719360.
Kim JH,Chang KH,Song IC,et al.Delayed encephalopathy of acute carbon monoxide intoxication:diffusivity of cerebral white matter lesions[J].AJNR Am J Neuroradiol,2003, 24(8):1592-1597.
[12]
Li Q,Cheng YM,Bi MJ,et al.Effects of N-Butylphthalide on the expressions of Nogo/NgR in rat brain tissue after carbon monoxide poisoning[J].Environ Toxicol Pharmacol,2015,39(2):953-961.
[13]
Yang YH,Liu Y,Wei P,et al.Silencing Nogo-A promotes functional recovery in demyelinating disease[J].Ann Neurol,2010,67(4):498-507.
[14]
Zhao NJ,Liang PC,Zhuo XY,et al.After treatment with methylene blue is effective against delayed encephalopathy after acute carbon monoxide poisoning[J].Basic Clin Pharmacol Toxicol,2018,122(5):470-480.
[15]
Beppu T,Nishimoto H,Ishigaki D,et al.Assessment of damage to cerebral white matter fiber in the subacute phase after carbon monoxide poisoning using fractional anisotropy in diffusion tensor imaging[J].Neuroradiology,2010,52(8):735-743.
Shen MH,Zheng YJ,Zhu KM,et al.Hydrogen gas protects against delayed encephalopathy after acute carbon monoxide poisoning in a rat model[J].Neurol Res,2020,42(1):22-30.
[19]
Zhang JF,Guo YW,Li WY,et al.The efficacy of N-Butylphthalide and dexamethasone combined with hyperbaric oxygen on delayed encephalopathy after acute carbon monoxide poisoning[J].Drug Des Devel Ther,2020,14:1333-1339.
[20]
Xiang WP,Xue H,Wang BJ,et al.Combined application of dexamethasone and hyperbaric oxygen therapy yields better efficacy for patients with delayed encephalopathy after acute carbon monoxide poisoning[J].Drug Des Devel Ther,2017,11:513-519.